Ren-Huang Wu

Title: Ren-Huang Wu: Innovator in Neurotensin Receptor Research

Introduction

Ren-Huang Wu is a notable inventor based in Miaoli, Taiwan. He has made significant contributions to the field of biotechnology, particularly in the development of humanized antibodies targeting neurotensin receptor 1 (NTSR1). His work has implications for treating various diseases and disorders related to NTSR1 activity.

Latest Patents

Ren-Huang Wu holds a patent for "Humanized anti-human neurotensin receptor 1 antibodies and their uses." This patent describes a humanized anti-neurotensin receptor 1 (NTSR1) antibody or an antigen-binding fragment thereof. It also outlines methods for treating, prophylactic treating, and preventing diseases and disorders caused by or related to NTSR1 activity and signaling. Additionally, the patent includes a method or kit for detecting NTSR1 in a sample.

Career Highlights

Throughout his career, Ren-Huang Wu has worked with prominent institutions such as the Development Center for Biotechnology and the National Health Research Institutes. His research has focused on advancing the understanding of neurotensin receptors and their potential therapeutic applications.

Collaborations

Ren-Huang Wu has collaborated with notable colleagues, including Pei-Shan Wu and Han-Shu Hu. These partnerships have contributed to the advancement of research in the field of neurobiology and biotechnology.

Conclusion

Ren-Huang Wu's innovative work in developing humanized antibodies for neurotensin receptor 1 showcases his commitment to advancing medical science. His contributions have the potential to lead to significant breakthroughs in treating related diseases and disorders.